{"pageContent": "Background: According to the American Cancer Society, prostate cancer ranks second in terms of mortality and is a front-runner of newly detected cases. Conventional therapies neither eradicated cancer nor increased the life expectancy of patients obviating the need for less toxic as well as efficient therapies to treat cancer. Gene therapy alone, or in combination with conventional therapies, possesses a strong potential to combat cancer.", "metaData": {"source": "Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system\nhttps://pubmed.ncbi.nlm.nih.gov/28662291/"}}